chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client received the Pfizer Covid-19 Vaccine (Lot #EW0167 Exp. 08/2021) at 10:58 AM. Client was in the presence of his sister when he requested to sit outside for fresh air during his 15 minute observation. EMT acknowledged his request and the client sat outside near the entrance while EMT stood near the entrance. Client was with his sister and mother and was checked on every 5 minutes by EMT to see how he was feeling. Client's family seemed unconcerned and the client stated that he had a fear of needles. However, after 10 minutes, client began to complain of feeling like "fainting." Client was a 26 year old male alert and tracking and anxious. Client had a chief complaint of a low heart rate. This was the client's first dose of the Pfizer vaccine and he denied any chronic illness or allergies. Clients blood pressure while sitting up was 88/38 and heart rate was 48 and regular at the radial. Client had no swelling, hives, discoloration, shortness of breath or other signs of anaphylaxis. Client's airway, breathing and circulation were intact and was alert and oriented to person, place, date and event. Client's remaining vitals were respirations 14, eyes 5mm and sluggish, O2 saturation 98%, lung sounds clear bilaterally and temperature 98 degrees f. EMTS brought an observation bed outside to allow the client to lay down and continued to taking vitals at 5 minute intervals. Client's blood pressure improved to 108/72 but heart rate continued to remain low and hovered at the high forties. At 1133 client consented to having EMTs call 911 due to his low heart rate. 911 was called at 1137 and arrived at 1142. Vitals were continuously monitored until firefighters arrived and were as follows: 1123 - 108/76, 52, 14, 02 98%, 1128 - 108/72, 52, 14, O2 97, 1133 - 108/68, 48, 14, O2 98%, 1138 - 108/68, 48, 14, O2 98%, 1138 - 108/72, 48, 14, O2 98%. Paramedics and the fire department assumed care at 11:42. Client was assessed by paramedics and firefighters while on site and it was at this time that client revealed he was under the influence of "edibles." Client consented to EMS transport and departed  with Paramedic unit 6 and Fire Engine 7 at 1151. Client transported to Hospital. Registered nurse remained with the patient's mother and daughter to answer their questions and provide emotional support. VAERS completed, confirmation number        .
Within about an hour of the Moderma Vaccine in left arm.  I felt numbness on my left cheek, left eye site peripheral vision wasn't great, and couldn't hold a coffee cup easily in the left hand, it wasn't strong.   My cheek felt like I had mild novocaine in it, like when I had a tooth pulled.   Then,  4  1/2 hrs after the shot I was very tired and couldn't keep my eyes open.    Now at 8:30 pm after dinner, I feel much better and like myself again.  I think this is a small price to pay to get the vaccine.
light headed; nauseous; not sleeping well; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headed), NAUSEA (nauseous) and INSOMNIA (not sleeping well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (light headed), NAUSEA (nauseous) and INSOMNIA (not sleeping well). At the time of the report, DIZZINESS (light headed), NAUSEA (nauseous) and INSOMNIA (not sleeping well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided  Treatment information include numbing cream.    Reporter did not allow further contact
Rash flat; Vesicles spread across body; This is a spontaneous report from a non-contactable healthcare professional. A 38-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7484) via an unspecified route of administration on an unknown date in Aug2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On an unknown date in Aug2021, the patient experienced rash flat and with vesicles spread across body within 48 hours. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the rash flat and vesicles which included treatment with unspecified anti-histamines and unspecified topical pain ointments. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events rash flat and vesicles were unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered from vaccine that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient have been administered from vaccine that experienced a T excursion) in a 78-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered from vaccine that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient have been administered from vaccine that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient have been administered from vaccine that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient have been administered from vaccine that experienced a T excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication information was provided. No treatment medication information was given. The patient did not have any adverse events post injection. It was reported that the storage condition at the time of the excursion was at refrigerator. Maximum temperature reached was 64-degree Fahrenheit, and excursion duration was approximately 7 hours. The vials were returned to the refrigerator. No changes in visual inspection. Pertinent details: At the time they were unpunctured. As per source document the Tran date was reported as 25-Mar-2022.
patient with palpitations, had intermittent non-sustained episodes of SVT lasting seconds and spontaneously resolving without any hemodynamic instability noted on 3/9/22 at ED, unknown underlying cause, admitted for monitoring given symptomatic
disorientation, light headedness, extensive soreness, severe shortness of breath,  severe feebleness, tiredness, hallucinations, fever, chills, migraine, severe chest pain,  loss of appetite, dehydration, minor physical exertion made me short of breath and have an elevated heartrate
25 minutes after vaccine shot: throat started to get itchy 30 minutes after vaccine shot: roof of mouth and tongue started to get itchy - went to see nurse :  took 50mg Benadryl  40 minutes after vaccine shot: difficulty swallowing: need to clear throat 50 minutes after vaccine shot: nurse suggested taking my EpiPen but I was still able to breathe (all other symptoms were still very present Approximately 25-30 minutes after taking Benadryl symptoms began to subside.  No EpiPen was administered.  Approximately 95 minutes after vaccine shot: symptoms were reduced enough to go home.
This is a spontaneous report from a 55 year old female pt who, approximately 3 hours post vax, experienced sudden body tremors, hands shaking and her insides shaking. Also, she developed a sharp pain in the injected left arm. The next morning, the body tremors ceased but the arm pain persisted another 3 days. Approximately 2 weeks after the injection, she experienced a dull pain which was intermittent and tingling of her neck which radiated down her left arm. The symptoms were treated with Benadryl. The most recent information received on 7/2/99, reports the pain in arm and neck appears to be ongoing. Her doctor suggested she take cortisone but she does not want to. The physician attributes the arm pain to the arthritis, but the pt does not believe this because she never had pain there before.
Headache, chills, body aches (lower back, legs and neck). Tiredness, nausea, low grade fever 99.9, dizziness. Symptoms started early on 1/21/21 and lasted till 1/23/21 in the morning.
Patient reports red, swollen arm post vaccine. Resolved with BENADRYL and ZYRTEC.
Circular elevated area, erythematous, pruritic.  OYC Benadryl, monitor
Heat sensation inside throat and neck  Swelling of glands within throat  Unable to pass regular saliva  Unable to breathe  Heavy breathing  Feeling tingling in body  Torso aching back and front and fore arms  Very heavy feeling  Headaches  Runny Mucus  Coughing  Spitting saliva, runny saliva as wanting to throw up Time lapse approximately 2 hours and I can?t remember time -
Vaccine administered after temperature excursion; Vaccine administered after temperature excursion/ vaccine administered after being frozen at 23 degree fahrenhiet; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion/ vaccine administered after being frozen at 23 degree fahrenhiet) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In November 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion/ vaccine administered after being frozen at 23 degree fahrenhiet). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion/ vaccine administered after being frozen at 23 degree fahrenhiet) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported.  No treatment medication reported.  It was reported that 10 vials out of 15 doses each were stored in a freezer whose temperature range was at all times from 24.3 degree Fahrenheit to 24.7 degree Fahrenheit.  The healthcare provider mentioned that they always had the freezer between this temperature range.   Two vials were used to administer to healthcare provider's office employees. All doses were injected intramuscularly in deltoid muscle.  The reporter informed that, the vaccine was administered after being frozen at 23 degrees Fahrenheit since receipt.  Vaccine administration dates were reported as 23-Nov-2021 and 27-Nov-2021.  The patient did not experience any adverse events after receiving the booster dose of vaccine and the healthcare provider was informed that the vaccine could be used until the date of expiration.   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2022: Significant Follow up received: contains updated outcome of the event of product storage error and narrative updated.
This spontaneous report was received from a nurse referring to an unspecified patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On an unspecified date, the patient received improperly stored dose of GARDASIL 9 Intramusculary (dose, Lot # and expiration date were not reported) for prophylaxis. The vaccine underwent a temperature of 8.6 Centigrade during 14 hours, not detected by data logger. There was a previous temperature excursions of 8.8 Centigrade during 14 hours. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
When pushed the plunger of the syringe in,  the syringe popped off the needle and the client only got a sub dose of bivalent vaccine.   The client did not want us to contact our provider on call for further guidance said "it is what it is and can happen to anyone" then the client left the clinic.
CO  SOB, light headedness and tachycardia HR 110 BP 150/palp, O2 Sat 94% on RA  Provided O2 @ 2liters via NC. Patient reported reduction in symptoms within a few minutes and discharged to self with husband.   At discharge HR 83, BP 150/96, O2 Sat 93% on RA
Three hours after receiving my first Covid vaccine, I suddenly got two large bumps on my tongue. About a minute later, I couldn't speak clearly. Next, I got extremely dizzy, to the point I couldn't stand up. After that, I got a rash across my chest, then my shin started tingling. Finally, my scalp started tingling as well. This went on for about 10 minutes and then each symptom went away, one by one, until I was completely fine, as if it never occurred. I had not gone anywhere or done anything out of the ordinary that day besides drive from my home office to the fairgrounds for my shot and then came straight home. I don't know if I am supposed to get my second shot on 5/17/21, as my doctor told me I need to talk to the CDC.
Pain around injection site. Very large area of pain, entire upper limb hurt and pain wrapped around sides and back of limb. Worst pain lasted for 3 days. Lingering pain for 7 additional days.
I had nausea, low grade fever, and 2 days later started having a rash at the vaccination site.
When Pt came to the pharmacy today for her booster shot, she reported long standing arm tingles and 'pain' that traveled down her right arm. The discomfort began after the shot was received 3 weeks ago and has not improved. She was insistent on getting the booster shot today, however, we advised her to contact a provider and get the arm tingling looked at before a second COVID shot is given. She refused to go to a doctor for evaluation. We did not give her the booster vaccine today. The phone number provided on this form is for Pt neighbor. Pt does not have a phone. We consulted 2 other medical sources and were given the advice to not immunize her at this time. We offered her names and phone numbers of local clinics where she could get the vaccine and have medical personnel available to observe her.
patient's physician administers PNEUMOV AX 23 every 8 years to the patient, because the patient has asthma; This spontaneous report was received from a pharmacist concerning a female patient of an unknown age    The patient's concurrent conditions included asthma. The patient's medical history and concomitant medication were not provided.        On an unspecified date, the patient started therapy with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) (dose, frequency, route, lot# and expiration date were not provided) for prophylaxis.      The pharmacist stated that the patient's physician administered Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) to the patient, because the patient had asthma. The last date of administration of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) was 08-NOV-2012.
Headache on the left side, left sided ear, jaw and neck pain going on 4 days. Extreme fatigue going on 4 days.; Headache on the left side, left sided ear, jaw and neck pain going on 4 days. Extreme fatigue going on 4 days.; Headache on the left side, left sided ear, jaw and neck pain going on 4 days. Extreme fatigue going on 4 days.; Headache on the left side, left sided ear, jaw and neck pain going on 4 days. Extreme fatigue going on 4 days.; Headache on the left side, left sided ear, jaw and neck pain going on 4 days. Extreme fatigue going on 4 days.; This is a spontaneous report from a contactable nurse (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number EL3248), via an unspecified route of administration in left arm on 08Jan2021 14:15 at a single dose for COVID-19 immunization. Medical history included migraines, anxiety, arthritis, EOE, IBS, asthma, possible autoimmune disorder AS, and known allergies with caffeine. Concomitant medications included topiramate (TOPAMAX), buspirone hydrochloride (BUSPAR), paracetamol (TYLENOL), montelukast sodium (SINGULAIR), and multivitamin. The patient previously took scopolamine allergies. The patient experienced headache on the left side, left sided ear, jaw and neck pain going on 4 days, extreme fatigue going on 4 days, since 08Jan2021 22:00. The event resulted in doctor or other healthcare professional office/clinic visit. The patient has no COVID prior vaccination, has not been tested for COVID post vaccination. Treatment for the events included MEDROL dose pack and TYLENOL. The outcome of the events was unknown.
Fever chills headache nausea body aches for 72 hours. Swollen lymph nodes and red hot hard swollen arm still ongoing
Later that day I felt extreme fatigue, lack of appetite, thirst and pain and swelling at the injection site spreading to my whole arm and swelling my underarm area. Extremely painful arm due to swelling, especially underarm area. I had chills and felt sick. That night when I tried to sleep my heart rate was really high all night, but seemed to calm down the next day. Had to take pain relieving drugs for 3 days after in order to sleep. (Advil or Tylenol). Still have underarm swelling and pain and it is now 96 hours later.
Patient said she had no muscle pain or soreness immediately following the vaccine, but severe pain at vaccine site began about 1 week following the vaccine, and has continued. When the pain began she had trouble lifting a gallon of milk. At this point she has full range of motion but says it feels like the needle is still going into her arm. No redness, swelling, muscle wasting, nodule, or any other symptoms reported.
Information has been received from a physician concerning a 58 year old white female patient with allergic reaction to KEFLEX and sulfonamide allergy, and lung cancer stage 4 who on 14-OCT-2008 was vaccinated with PNEUMOVAX (lot # 659148/1382U) IM in the left arm.  Concomitant therapy included first dose of FLUZONE (lot # 02751AA) IM in the left arm.  On 15-OCT-2008 the patient experienced swollen left arm and arm redness.  Subsequently, the patient recovered from left arm swollen and arm redness.  Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; Vaccine brand other: Moderna; Vaccine brand: Pfizer/BioNTech; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 74-year-old male patient received BNT162b2 (BNT162B2), on 28Aug2020 at 12:00 as dose 1, single (Lot number: 1031), in left arm, on 18Sep2020 as dose 2, single (Lot number: 1001), in left arm and on 21Jul2021 at 12:00 as dose 3 (booster), single (Lot number: 1031) at the age of 73 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 22Mar2022 at 09:30 as dose 4 (booster), single (Lot number: 016J21-2A), in left arm and on 20Oct2022 at 16:00 as dose 5 (booster), single (Lot number: 049D22A), in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 22Mar2022 at 09:30, outcome "unknown", described as "Vaccine brand other: Moderna; Vaccine brand: Pfizer/BioNTech"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2023, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2023) Positive, notes: rebound tested positive on day 9. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient do not have any known allergies.; Sender's Comments: Based on the information available, the events Drug ineffective, COVID-19 and Interchange of vaccine products are assessed as related to BNT162B2 administration.
Product exposed to highest temperature of 17.6 degrees Celsius with no adverse event; This case was considered as non-case as temperature excursion reported without stability data and no patient involved.
8 hours post first covid vaccine patient wife called emergency room stating patient began complaining of itching, several minutes later noticed red and pimply bumps all over skin.  Extremely itchy and uncomfortable.  Denied fever or difficulty breathing or swallowing.   Recommended by triage nurse to be seen in ED.
The patient went to the emergency room who diagnosed her to have Cellulitis at the site of injection that spread to both upper extremities.
He received one dose of monovalent afterward and it seems to have helped his long term symptoms; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 26-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "covid delta ", start date: Aug2020 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "He received one dose of monovalent afterward and it seems to have helped his long term symptoms". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Reporter cousin who was 26 years old caught covid delta in Aug2020 and has been suffering since. He received one dose of monovalent afterward and it seems to have helped his long term symptoms.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
within minutes of vaccination : chest pressure, shortness of breath, tachycardia, heavy head, confusion, facial twitching, BP 200/113  EMS called. Benadryl 50 mg IM given according to patient. She refused EMS transport to ER.  3/14/2021 : shivering, diarrhea, severe body aches, fever 101.5F, loss of taste, nosebleed all day, headache  3/16/2021 : I performed a virtual visit for her case. Symptoms mostly resolved except fatigue, loss of taste, and headache.
34-year-old male presenting with lightheadedness and transient episode of hypertension following vaccine administration.  Appears most consistent with vasovagal episode and patient does report similar episodes in the past.  ECG performed without any acute ischemic change.  Symptoms have resolved by the time of my evaluation.  Blood pressure within normal limits.  No clinical features concerning for anaphylaxis